Fittex
Il-mediċini u l-apparati mediċi
Din l-iskeda informattiva tispjega r-regoli tal-UE dwar il-mediċini u l-apparat mediku, kif ukoll il-qafas legali robust fis-seħħ biex tiġi protetta s-saħħa pubblika u tiġi ggarantita s-sikurezza ta’ dawn il-prodotti. Dan jindirizza kwistjonijiet ewlenin fil-qasam, inkluż il-provvista tal-mediċini, il-ġlieda kontra r-reżistenza għall-antimikrobiċi, it-twettiq etiku tal-provi kliniċi u l-isfidi bħall-pandemija tal-COVID-19 u diversi avvenimenti ġeopolitiċi.
Is-saħħa pubblika
Din l-iskeda informattiva tiddeskrivi l-objettivi tal-politika tas-saħħa pubblika tal-UE u l-kuntest li fih żviluppat. Tippreżenta l-kisbiet ewlenin tal-UE biex tippromwovi s-saħħa u tipprevjeni l-mard, b’enfasi fuq il-kanċer u l-bini tar-reżiljenza għall-mard infettiv u t-theddid transfruntier għas-saħħa. L-isfidi tas-saħħa pubblika assoċjati mat-tibdil demografiku huma indirizzati, kif inhi wkoll il-ħtieġa li jiġi żgurat l-aċċess għal mediċini kritiċi. L-iżviluppi ta’ politika reċenti fis-saħħa ...
Policy analysis of potential modernised rights for patients in cross-border healthcare
The public policy ideal should be to provide high-quality healthcare to all EU citizens and residents in each Member State, also through cross-border cooperation, that, in turn, incentivises improvements in national healthcare systems. Difficulties in accessing cross-border healthcare become apparent when the coordination of public healthcare systems intersects with the free movement of market (private) healthcare services and goods. Inter alia, this paper presents the current challenges and possible ...
Health effects of fine particles - Assessing the health burden of fine particles and options for stronger EU action
This study examines the health effects of fine particulate matter (PM2.5 and PM10), trends in exposure, and the effectiveness of EU legal and policy frameworks. It draws on an umbrella review of 198 systematic reviews, quantitative analysis of exposure trends, stakeholder interviews, and comparative case studies across EU Member States. The study shows consistent health effects of PM2.5 exposure across multiple disease categories and identifies persistent inequalities in exposure across populations ...
Infographic - Childhood Cancer
This infographic presents the key facts and policy challenges surrounding childhood cancer, a rare but highly impactful disease that remains the leading disease-related cause of death beyond infancy in Europe. The infographic underlines that children are not small adults, but rather require specific approaches to diagnosis, treatment, research, rehabilitation, and long-term survivorship care. It also highlights the persistent inequalities in access to specialised paediatric oncology services across ...
It-tniġġis tal-arja u t-tniġġis akustiku
Din l-iskeda informattiva tispjega l-azzjoni tal-UE biex tnaqqas it-tniġġis tal-arja u t-tniġġis akustiku u tipproteġi s-saħħa tal-bniedem u l-ambjent. Tiddeskrivi s-sorsi u l-impatti ewlenin tat-tniġġis, l-objettivi ta’ tniġġis żero tal-UE u l-leġiżlazzjoni ewlenija li tindirizza l-emissjonijiet mill-industrija, mit-trasport u minn setturi oħra. Tenfasizza wkoll il-progress li sar u l-isfidi li fadal fir-rigward tat-titjib tal-kwalità tal-arja u t-tnaqqis tal-istorbju ambjentali.
This briefing provides a legal analysis and critical assessment of the genetically modified micro-organisms (GMM) component of the Commission proposal for a Directive amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs. This proposal was presented in December 2025 and accompanies the European Biotech Act. The briefing presents and analyses the proposed GMM-related amendments, situates the proposal ...
Threats from new and emerging plant pests - Options for EU management of pest outbreaks
New and emerging plant pests can undermine EU food security and farm/forestry incomes through yield losses, trade disruption and costly control measures, while also causing major environmental impacts through biodiversity loss, landscape change and increased pressure to use pesticides. Using a comprehensive foresight methodology, this study examines how global trade and tourism, climate change and agricultural systems contribute to the introduction and spread of new and emerging plant pests, assesses ...
Youth mental ill-health in the EU-27 is high, rising and increasingly associated with digital environments. This study shows how persuasive platform design, harmful content and emerging AI-mediated interactions amplify offline vulnerabilities in the context of under-resourced, fragmented services and a large 'missing middle' between schools and specialist care. Using seven country case studies and an EU-27 cost model, it estimates that youth mental ill-health will cost about €1.68 trillion over 2024 ...
European Biotech Act I - Scope, Regulatory Framework, Market Landscape and Competitiveness Context
The European Biotech Act I, proposed in December 2025, is the EU’s first standalone legislation regulating health biotechnology across its full lifecycle, from research to market placement. This briefing sets the Act’s scope and rationale against the sector’s economic weight and the widening global competitiveness gap. It maps the scope and regulatory landscape and places it in its competitiveness context. The briefing also profiles leading biotech hubs across Member States and identifies structural ...